FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:FirstString Research Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2791
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FirstString Research Inc (FirstString) is a biopharmaceutical company that discovers and develops therapies for inflammation and injury based medical conditions. The company markets new therapeutic products that enable physicians to treat unmet medical need. It offers therapeutic approach, which aims to address the disorders by concentrating on mitigating excessive inflammation, calming the inflamed tissue, and rebooting the body’s normal injury response mechanism to allow the healing process to become inhabited. FirstString offers topical granexin gel, which stabilizes gap junctions and tightens junctions of endothelial cells during the wound healing process. The company conducts preclinical programs in the fields such as ophthalmology, organ preservation and oncology. FirstString is headquartered in Mount Pleasant, South Carolina, the US.

FirstString Research Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FirstString Research Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FirstString Research Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
FirstString Research Raises USD15 Million in Series B Venture Financing 10
FirstString Raises USD6.5 Million in Venture Financing 11
Partnerships 12
Relief Therapeutics Enters into Partnership with FirstString Research 12
FirstString Research Enters into R&D Agreement with NCATS 13
Acquisition 14
Relief Therapeutics Acquires FirstString Research 14
FirstString Research Inc – Key Competitors 15
FirstString Research Inc – Key Employees 16
FirstString Research Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
FirstString Research Inc, Pharmaceuticals & Healthcare, Key Facts 2
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FirstString Research Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FirstString Research Inc, Deals By Therapy Area, 2012 to YTD 2018 8
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FirstString Research Raises USD15 Million in Series B Venture Financing 10
FirstString Raises USD6.5 Million in Venture Financing 11
Relief Therapeutics Enters into Partnership with FirstString Research 12
FirstString Research Enters into R&D Agreement with NCATS 13
Relief Therapeutics Acquires FirstString Research 14
FirstString Research Inc, Key Competitors 15
FirstString Research Inc, Key Employees 16

List of Figures
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FirstString Research Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lamar Advertising Company (LAMR):企業の財務・戦略的SWOT分析
    Lamar Advertising Company (LAMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Eddie Stobart Logistics Plc
    Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tillotts Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Tillotts Pharma AG (Tillotts), a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of var …
  • People’S Bank
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Agenus Inc (AGEN):企業の財務・戦略的SWOT分析
    Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nippon Suisan Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vertex Pharmaceuticals Inc (VRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Orkambi (ivacaftor/lumacaftor) and Kalyd …
  • Dialog Semiconductor plc (DLG):電力:M&Aディール及び事業提携情報
    Summary Dialog Semiconductor plc (Dialog) is a supplier of motor control ICs for automotive applications. The company’s product portfolio includes integrated power management, AC/DC power conversion, solid state lighting (SSL), Bluetooth low energy, mixed signal integrated circuits (ICs), hand-held …
  • Ardagh Group SA:戦略・SWOT・企業財務分析
    Ardagh Group SA - Strategy, SWOT and Corporate Finance Report Summary Ardagh Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mechel:企業のM&A・事業提携・投資動向
    Mechel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mechel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Swedish Orphan Biovitrum AB (SOBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Swedish Orphan Biovitrum AB (Sobi), formerly Biovitrum AB, is an integrated biopharmaceutical company that focuses on the development of products for the treatment of rare diseases. The company specializes in biotechnology with prime capabilities in protein biochemistry and biologics manufac …
  • OMV Petrom SA (SNP):企業の財務・戦略的SWOT分析
    OMV Petrom SA (SNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nippon Steel & Sumikin Chemical Co Ltd:企業の戦略的SWOT分析
    Nippon Steel & Sumikin Chemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Indivior Plc (INDV):企業の財務・戦略的SWOT分析
    Indivior Plc (INDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Glu Mobile Inc (GLUU):企業の財務・戦略的SWOT分析
    Glu Mobile Inc (GLUU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Bank of Canada:企業の戦略・SWOT・財務情報
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報
    Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆